Amniotic Membrane Market Value to Show $1,563 Million by 2023 : Allied Market Research

The amniotic membrane surrounds the embryo and protects it and surrounds the amniotic fluid. It is used as a skin substitute as well as surgical biomaterials in a variety of environments such as eye disease, treatment of pathological conditions including skin wound healing and reconstructive surgery.

The global amniotic membrane market was valued at $812 million in 2016, and is expected to reach $1,563 million by 2023, registering a CAGR of 9.7% during the forecast period.

The global amniotic membrane market is widely used in areas such as ophthalmology, genitourinary tract, skin, brain, head and neck, and other surgical operations. In addition, amniotic membrane transplant surgery has increased the amniotic membrane growth worldwide. However, the lack of skilled professionals hinders market growth. In addition, as the awareness of the benefits of amniotic membrane as well as of individuals as well as of medical professionals increases, the demand for amniotic membrane products will increase, which is expected to stimulate the worldwide amniotic membrane market.

The rise in geriatric population and the increased adoption of amniotic membrane for varied applications are the major factors that drive the growth of this market. However, dearth of healthcare professionals is the key restraint for the market growth. Moreover, the increase in awareness about the advantages of amniotic membrane in various surgical procedures that enhances the surgeries, would offer lucrative opportunities for the market growth in the foresee future.

Download Sample @ https://www.alliedmarketresearch.com/request-sample/4559?utm_source=OpenPR_sank

The lyophilized amniotic membrane segment is expected to grow at a significant CAGR during the forecast period as lyophilized amniotic membrane can be stored at ambient temperatures for prolonged periods. Moreover, nearly 240 pieces of amniotic membrane are obtained from a single amnion sheet.

The surgical wounds segment accounted for the maximum share in terms of revenue in 2016 and is expected to grow at a CAGR of 8.9% during the forecast period. This is due to the challenges posed by surgical wounds as they can result in complications such as surgical ulcers.

Ambulatory surgical centers is expected to register a significant growth rate of 9.9% during the forecast period owing to the advantages of ambulatory surgical centers such as less hospital stay and faster recovery post treatment.

Asia-Pacific is expected to witness highest growth rate in the global market and is expected to continue this trend throughout the forecast period. This is owing to high population density and rise in disposable income across the countries such as India and China. In addition, rapid growth in geriatric population and increase in number of ophthalmic diseases in the developing economies boost the market growth. For instance, China has 2.5 million individuals suffering from cataract and an estimated one million children suffer from blindness, which is mainly caused due to vitamin A deficiency. This creates an ample demand for upgraded surgeries employing amniotic membrane, fueling the market growth.

Key Findings of the Amniotic Membrane Market:

• The other applications segment accounted for about one-ninth share of the total market in 2016, and is expected to register a CAGR of 10.8% from 2017 to 2023.
• The ophthalmology segment accounted for one-fourth share of the total market in 2016 and is expected to grow at a high CAGR of 11.2% during the forecast period.
• The U.S. dominated the North American amniotic membrane market and is projected to grow at a CAGR of 9.2% from 2017-2023.
• Hospitals end user dominated the amniotic membrane market accounting for one-third share of the total market is expected to grow at a high CAGR of 10.0% during the forecast period.

The key players operating in the global amniotic membrane market are FzioMed, Inc., Skye Biologics Inc., IOP Ophthalmics, Amniox Medical, Inc., Amnio Technology, LLC, Applied Biologics LLC, Alliqua BioMedical, Inc., Human Regenerative Technologies, LLC, Derma Sciences Inc., and MiMedx Group, Inc. Other players operating in the value chain are AlloCure, Bellicum Pharmaceuticals, Biogen Idec, BIOTIME, Bone Therapeutics, Cell Medica, CESCA THERAPEUTICS, and Fibrocell Science.

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP,
provides business insights and market research reports to large as well as small &
medium enterprises. The company assists its clients to strategize business policies and
achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection
to investment advice. The analysts at Allied Market Research dig out factors that help
clients to understand the significance and impact of market dynamics. The company
amplies client’s insight on the factors, such as strategies, future estimations, growth
or fall forecasting, opportunity analysis, and consumer surveys among others. As
follows, the company offers consistent business intelligent support to aid the clients
to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.